Preclinical studies suggest that GLP‐1 receptor activation promotes C‐cell proliferation and increases the risk of thyroid cancer, including medullary thyroid carcinoma (MTC), in rodents, likely due to higher GLP‐1 receptor expression in thyroid cells [14, 15]. Here, GLP1R is linked to thyroid gland carcinoma.